8-METHOXY-2,4-DICHLOROQUINAZOLINE

8-METHOXY-2,4-DICHLOROQUINAZOLINE Suppliers list
Company Name: Shanghai YuYuan Pharmaceutical Co., Ltd.  Gold
Tel: 13052276172
Email: product@yuyuanpharm.com
Company Name: Heterochem  
Tel: 027-88041443 13072715837
Email: sales@hetero-chem.com
Company Name: Shanghai Topbiochem Technology Co., Ltd  
Tel: 021-58170097
Email: info@topbiochem.com
Company Name: Shanghai Keepontech Co.,Ltd  
Tel: 021-54849683 13601642561
Email: sales@keepontech.com
Company Name: Bide Pharmatech Ltd.  
Tel: 400-164-7117 18317119277
Email: product02@bidepharm.com

8-METHOXY-2,4-DICHLOROQUINAZOLINE manufacturers

8-METHOXY-2,4-DICHLOROQUINAZOLINE Basic information
Product Name:8-METHOXY-2,4-DICHLOROQUINAZOLINE
Synonyms:5-METHOXY-2,4-DICHLOROQUINAZOLINE;Quinazoline, 2,4-dichloro-5-methoxy-
CAS:61948-59-2
MF:C9H6Cl2N2O
MW:229.06
EINECS:
Product Categories:
Mol File:61948-59-2.mol
8-METHOXY-2,4-DICHLOROQUINAZOLINE Structure
8-METHOXY-2,4-DICHLOROQUINAZOLINE Chemical Properties
Melting point 165-166℃
density 1.450
storage temp. under inert gas (nitrogen or Argon) at 2-8°C
AppearanceOff-white to light brown Solid
Safety Information
HS Code 2933599590
MSDS Information
8-METHOXY-2,4-DICHLOROQUINAZOLINE Usage And Synthesis
Uses2,4-Dichloro-5-methoxyquinazoline is a useful reactant for the synthesis of N2,N4-disubstituted quinazoline-2,4-diamines which have been studied as possible antibacterial agents.
Synthesis
2,4(1H,3H)-Quinazolinedione, 5-Methoxy-

61948-86-5

8-METHOXY-2,4-DICHLOROQUINAZOLINE

61948-59-2

General procedure for the synthesis of 2,4-dichloro-5-methoxyquinazoline from 5-methoxyquinazoline-2,4(1H,3H)-dione (310 mg, 1.6 mmol): 5-methoxyquinazoline-2,4(1H,3H)-dione was added to a dry flask, followed by phosphorus trichloride (10 mL) and N,N-dimethylaniline (0.2 mL). After the addition was completed, the reaction mixture was heated to reflux for 4 hours. After completion of the reaction, the volatile components were evaporated under reduced pressure to obtain the crude product. Saturated sodium bicarbonate solution was added to the crude product, followed by ethyl acetate for extraction. The organic phase was separated, dried over anhydrous sodium sulfate and filtered. The solvent was again evaporated under reduced pressure to give another crude product. The crude product was purified by silica gel column chromatography with an eluent of 10% to 20% ethyl acetate/hexane mixed solvent, resulting in 2,4-dichloro-5-methoxyquinazoline (180 mg, 49% yield) as a white solid.1H NMR (400 MHz, CDCl3) δppm: 4.03 (s, 3H), 7.02 (d, J=8.35 Hz. 1H), 7.55 (d, J=8.35Hz, 1H), 7.85 (t, J=8.35Hz, 1H).

References[1] Patent: WO2007/30582, 2007, A2. Location in patent: Page/Page column 92
[2] Journal of the Chemical Society, 1948, p. 1759,1765
[3] Patent: US5688803, 1997, A
[4] Journal of Medicinal Chemistry, 2014, vol. 57, # 12, p. 5141 - 5156
Tag:8-METHOXY-2,4-DICHLOROQUINAZOLINE(61948-59-2) Related Product Information
CHLOROETHANE 5-Quinazolinol (7CI,8CI,9CI) 4-CHLORO-5-METHOXYQUINAZOLINE 8-METHOXY-2,4-DICHLOROQUINAZOLINE 4-Chloro-8-methoxyquinazoline 2-chloro-8-methoxyquinazoline 8-Quinazolinol (6CI,7CI,8CI,9CI)